Table 6.
Inherited/germline conditions involving lymphatic malformations.
Associated malformation or syndrome | Inheritance | Clinical phenotype | Candidate gene | Protein function or suspected role (if known) | Clinical evaluation | References |
---|---|---|---|---|---|---|
Primary lymphedema (Nonne-Milroy disease) | AD | • Lower-limb lymphedema, present as pedal edema at birth or soon after • Usually bilateral • Hydrocele (males) • Prominent veins • Upslanting toenails • Papillomatosis • Urethral anomalies in males |
FLT4
VEGFR3 |
• Endothelial cell tyrosine kinase receptor, important for lymphangiogenesis (VEGF-C receptor) • Transcription factor, regulates PDGFβ |
• MR lymphangiography or NM lymphoscintigraphy (lack of uptake radioactive colloid in ilioinguinal lymph nodes) • PT/OT evaluation • Compression fitting • Good skin hygiene • Genetic testing and counseling |
(3, 10, 11, 15) |
Late-onset lymphedema (Meige Disease) | Probable AD | • Most common subtype of primary lymphedema (~80% all cases) • Present at birth but onset of symptoms at puberty • Edema begins in feet and ankles and progresses to legs and knees |
FOXC2
GJC2 |
• Transcription factor, regulates PDGFβ• Gap junction protein | • Evaluation as per primary lymphedema plus • Evaluation to rule out secondary lymphedema (malignancy, thrombosis, etc.) |
(3) |
Microcephaly-lymphedema-chorioretinal dysplasia | AD, or sporadic | • Patients have persistence of fetal lymphedema • Hypotonia, • Microcephaly • Intellectual disability • Chorioretinopathy |
KIF11 | • Spindle motor protein, may affect microtubule function | • Evaluation as per primary lymphedema plus • Ophthalmology exam • Echocardiogram • Consider brain MRI (lissencephaly reported) |
(3, 15) |
Hypotrichosis-lymphedema-telangiectasia syndrome | AR | • Absent eyebrows and eyelashes • Eyelid edema from birth • Lymphedema in the first of second decade of life • Telangiectasias (palms, soles, scalp, scrotum, legs) |
SOX18 | • Spindle motor protein, may affect microtubule function | • Evaluation as per primary lymphedema plus • Serial echocardiogram (dilation of the ascending aorta reported) • Skin and nail exam |
(3, 15) |
Lymphedema with distichiasis | AD | • Late onset lymphedema with distichiasis (fine hairs from Meibomian glands on inner eyelid) • Variable cardiac/renal/palate defects, varicose veins • Neck webbing |
FOXC2 | • Transcription factor, regulates PDGFβ | • Evaluation as per primary lymphedema plus • Ophthalmology exam (corneal irritation, recurrent conjunctivitis, and photophobia, ptosis) • Echocardiogram to rule out congenital heart disease • Spine MRI to rule out extradural arachnoid cysts |
(3, 49) |
Lymphedema with choanal atresia | AR | • Exceedingly rare, 1 family with lymphedema and choanal atresia | PTPN14 | • Loss of function mutation in protein tyrosine phosphatase | • Evaluation as per primary lymphedema | (3) |
Cholestasis-lymphedema (Aagenaes Syndrome) | AR | • Jaundice at birth and recurrent through life • Can progress to cirrhosis • Late-onset lower extremity lymphedema • Identified in several Norwegian families |
Unknown gene on 15q | • Unknown | • Evaluation as per primary lymphedema plus • Hepatic/GI evaluation including CMP, serum bile acids (elevated), and lipid panel (hyperlipidemia) |
(3) |
Lymphedema-intestinal LM-mental retardation (Hennekam Syndrome) | AR | • Severe progressive lymphedema including genitalia and face • Mild to severe intellectual disability • Hypoproteinemia • Hearing loss • Renal anomalies • Scoliosis and club feet • Microcephaly ad craniosynostosis |
CCBE1
FAT4 ADAMTS3 |
• Function in migration of lymphatic endothelial cells | • Evaluation as per primary lymphedema plus • Neurologic evaluation • Hearing screen • Abdominal US • Nutritional assessment • Thyroid studies • Screening for anemia • Spine X-rays |
(3, 50–52) |
Lymphedema-myelodysplasia (Emberger syndrome) | AD | • Lymphedema of limbs and genitalia in early childhood • Myelodysplasia with development of AML • Craniofacial anomalies • Congenital deafness |
GATA2 | • Transcription factor involved in gene regulation during vascular development and hematopoietic differentiation | • Evaluation per primary lymphedema plus • Hematologic evaluation including bone marrow biopsy • Neurologic and hearing assessments |
(3, 53) |